Spinal blood flow and metabolism in neurological diseases

Spinal blood flow and metabolism in neurological diseases - Spinal blood flow and metabolism in neurological diseases

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011111

Enrollment

Registered

2013-07-15

Start date

2013-07-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

motor neuron disease including ALS, multiple sclerosis, stroke, Parkinson disease, spinocerebellar degeneration, multiple system atrophy

Interventions

PET scan study with 11C-flumazenil PET scan study with 18F- FDG PET scan study with 15O-H2O

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatient or ambulatory patient of Department of Neurology, Okayama University Hospital. And these patienets are diagnosised as motor neuron disease incluiding ALS, multiple sclerosis, stroke, parkinson disease, spinocerebellar ataxia, and multiple system atrophy

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Signal intensity of each PET image (11C- flumazenil,18F- FDG, 15O-H2O) (spinal cord C1-C6 level)	—

Countries

Japan

Contacts

Public ContactToru Yamashita

Okayama University Hospital Neurology

toruyamashita@cc.okayama-u.ac.jp086-235-7365

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026